Idiopathic sensorineural hearing loss in the only hearing ear
- PMID: 27196076
- PMCID: PMC4907158
- DOI: 10.14639/0392-100X-587
Idiopathic sensorineural hearing loss in the only hearing ear
Abstract
A retrospective chart review was used for 31 patients with sudden, progressive or fluctuating sensorineural hearing loss (SHL) in the only hearing ear who had been consecutively evaluated at the ENT, Audiology and Phoniatrics Unit of the University of Pisa. The group of patients was evaluated with a complete history review, clinical evaluation, imaging exam (MRI, CT), audiologic tests (tone and speech audiometry, tympanometry, study of stapedial reflexes, ABR and otoacoustic emission) evaluation. In order to exclude genetic causes, patients were screened for CX 26 and CX30 mutations and for mitochondrial DNA mutation A1555G. Patients with sudden or rapidly progressive SHL in the only hearing ear were treated with osmotic diuretics and corticosteroids. In patients who did not respond to intravenous therapy we performed intratympanic injections of corticosteroid. Hearing aids were fitted when indicated and patients who developed severe to profound SHL were scheduled for cochlear implant surgery. The aim of this study is to report and discuss the epidemiology, aetiopathogenesis, therapy and clinical characteristic of patients affected by SHL in the only hearing hear and to discuss the issues related to the cochlear implant procedure in some of these patients, with regard to indications, choice of the ear to implant and results.
Uno studio retrospettivo è stato condotto su 31 pazienti, giunti all’osservazione della cinica ORL Audiologia e Foniatria dell’Università di Pisa dal 2007 al 2013, affetti da ipoacusia neurosensoriale improvvisa, fluttuante o progressiva nell’unico orecchio udente. L’intero gruppo di pazienti è stato valutato con una adeguata anamnesi, otomicroscopia, esami di imaging (TC RMN), test audiologici (audiometria tonale e vocale, impedenziometria, potenziali evocati uditivi e otoemissioni acustiche). Questo gruppo di pazienti è stato sottoposto anche a una valutazione genetica (ricerca mutazioni CX 26, CX 30 e DNA mitocondriale A1555G) e a test di laboratorio. I pazienti con ipoacusia improvvisa o rapidamente progressiva sono stati trattati con diuretici osmotici e corticosteroidi (endovena o intratimpanici). I pazienti che non hanno recuperato in maniera adeguata dopo il trattamento sono stati avviati a un percorso di protesizzazione. Nei pazienti con insufficiente resa protesica sono stati sottoposti ad impianto cocleare. Lo scopo di questo studio è quello di discutere l’epidemiologia, l’eziopatogenesi e le caratteristiche cliniche di pazienti affetti da ipoacusia neurosensoriale nell’unico orecchio udente e inoltre discutere le indicazioni e la scelta dell’orecchio da impiantare in questa categoria di pazienti.
Keywords: Cochlear implant; Only hearing ear; Progressive sensorineural hearing loss; Sensorineural hearing loss.
© Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.
Similar articles
-
Cochlear implant outcomes in adults and adolescents with early-onset hearing loss.Ear Hear. 2012 Mar-Apr;33(2):209-20. doi: 10.1097/AUD.0b013e31822eb16c. Ear Hear. 2012. PMID: 21934504
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Pediatric fluctuating sensorineural hearing loss: problems in medical management.Laryngoscope. 2001 Jan;111(1):21-5. doi: 10.1097/00005537-200101000-00004. Laryngoscope. 2001. PMID: 11192894
-
[Binaural asymmetric sensorineural hearing loss in audiological practice].Otolaryngol Pol. 2010 Nov-Dec;64(6):382-4. doi: 10.1016/S0030-6657(10)70591-6. Otolaryngol Pol. 2010. PMID: 21302506 Polish.
-
Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy.Pharmacotherapy. 2017 Dec;37(12):1600-1616. doi: 10.1002/phar.2044. Pharmacotherapy. 2017. PMID: 29023930 Review.
Cited by
-
Role of microRNA in inner ear stem cells and related research progress.Am J Stem Cells. 2020 Apr 25;9(2):16-24. eCollection 2020. Am J Stem Cells. 2020. PMID: 32419976 Free PMC article. Review.
-
Contralateral delayed endolymphatic hydrops: Clinical features and long term outcome.J Otol. 2021 Oct;16(4):205-209. doi: 10.1016/j.joto.2021.02.003. Epub 2021 Feb 26. J Otol. 2021. PMID: 34548865 Free PMC article.
-
Sudden Sensorineural Hearing Loss in the Only Hearing Ear: Large Vestibular Aqueduct Syndrome.Case Rep Otolaryngol. 2016;2016:8909124. doi: 10.1155/2016/8909124. Epub 2016 Nov 27. Case Rep Otolaryngol. 2016. PMID: 28018692 Free PMC article.
-
Cochlear Implants in Patients with Fluctuant or Progressive Hearing Loss on the Better Ear.Int Arch Otorhinolaryngol. 2021 Jan;25(1):e129-e134. doi: 10.1055/s-0040-1702970. Epub 2020 May 13. Int Arch Otorhinolaryngol. 2021. PMID: 33542763 Free PMC article.
References
-
- Stahl N, Cohen D. Idiopathic sudden sensorineural hearing loss in the only hearing ear: patient characteristics and hearing outcome. Arch Otolaryngol Head Neck Surg. 2006;132:193–195. - PubMed
-
- Hawkins DB. Hearing rehabilitation in a patient with sudden sensorineural hearing loss in the only hearing ear. Am Acad Audiol. 2008;19:267–274. - PubMed
-
- Pyykkö I, Ishizaki H, Peltomaa M. Azathioprine with cortisone in treatment of hearing loss in only hearing ear. Acta Otolaryngol Suppl. 1997;529:83–85. - PubMed
-
- Nadol JB, Jr, Weiss AD, Parker SW. Vertigo of delayed onset after sudden deafness. Ann Otol Rhinol Laryngol. 1975;84:841–846. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous